Hunt Anthony 4
4 · REPLIGEN CORP · Filed Nov 13, 2025
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
Hunt Anthony
Director
Transactions
- Sale
Common Stock
2025-11-12$156.65/sh−4,959$776,827→ 112,303 total - Sale
Common Stock
2025-11-12$155.85/sh−4,740$738,729→ 117,262 total - Sale
Common Stock
2025-11-12$158.01/sh−11,096$1,753,279→ 101,207 total - Sale
Common Stock
2025-11-12$158.51/sh−464$73,549→ 100,743 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-12−25,000→ 157,344 totalExercise: $33.87Exp: 2028-03-01→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2025-11-12$33.87/sh+25,000$846,750→ 125,743 total - Sale
Common Stock
2025-11-12$154.92/sh−3,741$579,556→ 122,002 total
Footnotes (7)
- [F1]Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 9, 2024.
- [F2]$154.92 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.26 to $155.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]$155.85 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.28 to $156.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]$156.65 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.31 to $157.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]$158.01 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.41 to $158.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]$158.51 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.43 to $158.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F7]207,344 of the shares underlying this option have vested. The remaining shares vest as follows: 28,777 shares on March 1, 2026, and 28,778 shares on March 1, 2027.